DENTALIS Animal Health develops products to improve the oral health of pets

MONTREAL–(BUSINESS WIRE)–Animal health veterans and human dental experts have teamed up and formed a startup dedicated to developing premium oral care products for pets, currently developing anti-tartar products non-invasive, using exclusive patented technology.

The new company, DENTALIS Santé Animale, is headquartered in Montreal and is led by:

  • CEO David Hauptman

  • President and Director of Product Development Kevin McDonnell, serial entrepreneur and co-founder of TetraGenx Animal Heath, Provetica AH and Vetio AH.

  • Scientific Director Hansruedi Siegrist, former Global Head of Technical Development at Novartis Animal Health and Management Consultant at Elanco AH.

  • Director of Regulatory Affairs, Jennifer (Rice) Thayer. Founder of Knotty Tide Consulting

“The DENTALIS AH team, with its impressive track record, will use new technology to develop superior oral care products for pets,” said Chairman Kevin McDonnell.

Three products are in development, reports DENTALIS.

McDonnell predicted rapid growth for DENTALIS.

“By mid-2024, assuming positive development results, DENTALIS expects its first product to be approved and forecasts potential revenues of up to $25 million in its first commercial year,” said he declared.

About Dentalis

We strive to discover new ways to improve and extend the lives of our pets through scientific innovations in oral health.

Boyd S. Abbott